ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
China flag China · Delayed Price · Currency is CNY
37.46
+0.22 (0.59%)
Apr 30, 2026, 2:04 PM CST

ChengDu ShengNuo Biotec Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
207.47281.05218.71219.13372.12211.56
Trading Asset Securities
90.2520.2520.1650-200
Cash & Short-Term Investments
297.72301.3238.86269.13372.12411.56
Cash Growth
60.71%26.14%-11.25%-27.68%-9.58%217.74%
Accounts Receivable
208.13177.98125.2115.89119.16111.73
Other Receivables
15.7114.817.9710.2723.639.49
Receivables
223.84192.79133.17126.16142.79121.22
Inventory
360.61336.17304.75194.33135.43101.36
Prepaid Expenses
---0.22--
Other Current Assets
65.951.1641.4219.4715.5417.85
Total Current Assets
948.07881.43718.21609.3665.89652.01
Property, Plant & Equipment
772.22773.03727.43483.86285.1238.06
Long-Term Investments
161.54157.06111.0494.4355.699.9
Other Intangible Assets
80.3780.9440.235.4836.336.48
Long-Term Deferred Tax Assets
13.2912.979.484.043.843.46
Long-Term Deferred Charges
16.4416.5714.119.9815.4310.93
Other Long-Term Assets
16.5212.5327.4468.6445.755.78
Total Assets
2,0081,9351,6481,3161,108956.62
Accounts Payable
81.5499.57108.5451.0528.557.83
Accrued Expenses
14.4625.547.4648.1257.0149.65
Short-Term Debt
179.52205.54200.1637.0350.4130.05
Current Portion of Long-Term Debt
80.77179.4399.6334.052-
Current Portion of Leases
--0.60.820.750.68
Current Income Taxes Payable
21.6817.212.618.745.074.19
Current Unearned Revenue
15.6950.8826.899.5317.9914.59
Other Current Liabilities
53.148.3857.5851.9363.2155.48
Total Current Liabilities
446.76626.52543.46241.28225162.46
Long-Term Debt
316.14150.16182.03189.1948.05-
Long-Term Leases
---0.61.422.17
Long-Term Unearned Revenue
33.9634.734.094.565.726.85
Long-Term Deferred Tax Liabilities
----1.07-
Other Long-Term Liabilities
86.965.52----
Total Liabilities
883.76876.93729.58435.63281.27171.48
Common Stock
157.39157.39112.421128080
Additional Paid-In Capital
348.16347.43389.59379.22408.36407.25
Retained Earnings
619.14552.78416.33388.71338.37297.89
Total Common Equity
1,1251,058918.34879.93826.74785.14
Minority Interest
---0.020.17--
Shareholders' Equity
1,1251,058918.32880.1826.74785.14
Total Liabilities & Equity
2,0081,9351,6481,3161,108956.62
Total Debt
576.43535.13482.42261.7102.6432.89
Net Cash (Debt)
-278.7-233.83-243.567.43269.48378.68
Net Cash Growth
----97.24%-28.84%192.35%
Net Cash Per Share
-1.76-1.48-1.530.051.732.68
Filing Date Shares Outstanding
158.01157.39157.39156.8156.8156.8
Total Common Shares Outstanding
158.01157.39157.39156.8156.8156.8
Working Capital
501.31254.91174.75368.03440.89489.55
Book Value Per Share
7.126.725.835.615.275.01
Tangible Book Value
1,044976.66878.15844.45790.44748.66
Tangible Book Value Per Share
6.616.215.585.395.044.77
Buildings
--235.44104.44101.2996.46
Machinery
--318.26254.4644.74198.53
Construction In Progress
--348.97274.3783.6450.06
Source: S&P Global Market Intelligence. Standard template. Financial Sources.